Company Number: 14421007

Analysis Date: 2025-07-20 12:12 UTC

1. Credit Opinion: DECLINE. The company is a recently incorporated micro-entity in the specialist medical practice sector with minimal financial history. Its latest balance sheet shows very limited net assets (£22) and negligible working capital. Such a fragile capital base and lack of meaningful financial scale imply limited capacity to service debt or absorb financial shocks. Furthermore, the company employs only one person and has very low current assets, indicating minimal operational scale and cash flow. Without stronger financials or evidence of stable revenue generation, the credit risk is elevated.

2. Financial Strength: The balance sheet indicates extremely limited financial strength. Net current assets have decreased sharply from £100 in 2023 to £22 in 2024. The company shows minimal capital reserves and total net assets of only £22. Current liabilities of £300 are almost equal to current assets of £322, leaving a very tight working capital margin. The fixed asset position is absent, suggesting no tangible long-term asset backing. Overall, the financial footing is very weak, reflecting an early-stage operation without significant retained earnings or buffer.

3. Cash Flow Assessment: Cash balances are minimal (reported £100 in 2023, not specifically disclosed for 2024 but implied low by total current assets figure). Working capital is positive but marginal (£22), which offers minimal liquidity to cover short-term liabilities. Given the micro-entity filing status and the single employee, cash generation capacity appears very limited. No information on receivables, payables turnover, or cash flow statements is provided, but the slim asset base and liabilities suggest tight cash flow management and potential liquidity risk.

4. Monitoring Points:

• Monitor future net asset growth and working capital improvements.
• Watch for any increase in turnover or profitability in subsequent filings.
• Keep track of director changes or any related party transactions given the controlling interest of Mr. Samir Zebari.
• Review for timely filing compliance and any indications of financial distress or restructuring.
• Observe whether the company expands employee base or asset holdings, which would support operational scale.